pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    BDTX-4933
    Metastatic Colorectal Cancer Les Laboratoires Servier SAS
  • Preclinical
    BEA-17
    Glioblastoma Multiforme (GBM) Beactica Therapeutics AB
  • Phase 2
    BEAM-201
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$BEAM Beam Therapeutics Inc.
  • Preclinical
← prev
page 12 of 62
next →
Pain89
Neurology1
BG-22
Solid Tumor
BioStar Pharmaceuticals Inc
  • Preclinical
    BGA-002
    Small-Cell Lung Cancer Biogenera SpA
  • Phase 2
    BGB-16673
    Refractory Chronic Lymphocytic Leukemia (CLL)$ONC BeOne Medicines Ltd.
  • Phase 1
    BGBB-2033
    Metastatic Hepatocellular Carcinoma (HCC)$ONC BeOne Medicines Ltd.
  • Phase 1
    BGC-515
    Malignant Mesothelioma BridGene Biosciences Inc
  • Preclinical
    BGI-9004
    Malignant Mesothelioma BridGene Biosciences Inc
  • Phase 1
    BH-30236
    Refractory Acute Myeloid Leukemia BlossomHill Therapeutics Inc
  • Phase 1
    BH-3120
    Solid Tumor Hanmi Pharmaceuticals Co Ltd
  • Phase 2
    BHV-1510
    Solid Tumor$BHVN Biohaven Ltd.
  • Phase 1
    BHV-1530
    Glioblastoma Multiforme (GBM)$BHVN Biohaven Ltd.
  • Phase 2
    BI-1206
    B-Cell Non-Hodgkin Lymphoma BioInvent International AB
  • Phase 2
    BI-1808
    Mycosis Fungoides BioInvent International AB
  • Phase 2
    BI-836858
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Boehringer Ingelheim International GmbH
  • Phase 2
    BIO-106
    Solid Tumor BiOneCure Therapeutics Inc
  • Phase 1
    BJ-001
    Solid Tumor BJ Bioscience Inc
  • Phase 1
    BJ-005
    Solid Tumor BJ Bioscience Inc
  • Phase 1
    BLM-11D1
    Refractory Acute Myeloid Leukemia Sichuan Biokin Pharmaceutical Co Ltd
  • Phase 1
    BLM-14D1
    Gastrointestinal Tumor Sichuan Biokin Pharmaceutical Co Ltd
  • Phase 1
    BLM-17D1
    Endometrial Cancer Sichuan Biokin Pharmaceutical Co Ltd
  • Phase 1
    BMS-986416
    Diffuse Cutaneous Systemic Sclerosis Bristol-Myers Squibb Co
  • Phase 1
    BMS-986497
    Myelodysplastic Syndrome (Preleukemia) Bristol-Myers Squibb Co
  • Phase 2
    BMX-001
    High-Grade Glioma Biomimetix JV LLC
  • Phase 2
    BNT-111
    Metastatic Melanoma$BNTX BioNTech SE
  • Phase 3
    BNT-113
    Recurrent Head And Neck Squamous Cell Carcinoma$BNTX BioNTech SE
  • Phase 2
    BOLD-100
    Colorectal Cancer Bold Therapeutics Inc
  • Phase 2
    BOXR-1030
    Merkel Cell Carcinoma SOTIO Biotech AS
  • Phase 1
    BP-1002
    Refractory Acute Myeloid Leukemia$BPTH BIO-PATH HOLDINGS, INC.